Tag Archives: R&D

ITIF Reports on Economic and Innovative Opportunities from Brain R&D

Biotechnology is healing the world and saving lives on a daily basis by curing and preventing an array of diseases. Yet, when it comes to mental and neurological illnesses, there still remain a great many mysteries waiting to be solved. According to Information Technology & Innovation Foundation’s (ITIF) report, A Trillion-Dollar Opportunity: How Brain Research Can Drive Health and Prosperity, 50 million American adults suffer each year from neurodegenerative diseases, psychiatric disorders, and other brain Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , ,

Welcome to Montreal and to the 2015 BIO World Congress

EricksonBrent_BTN

Welcome to Montreal and to the 12th Annual BIO World Congress on Industrial Biotechnology. The theme of this conference is linking chemistry, biotechnology and agriculture to create new value chains.  That is what BIO is all about – bringing thought leaders, researchers and venture capitalists together and fostering R&D and business development opportunities that will allow us to further the important goal of creating the value chains that are the lifeblood of the biobased economy. At BIO, Read More >

Environmental & Industrial, Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

The Bio Report: What a Decade of Investment Tells Us About the Health of Biotech

Emerging Therapeutic Company Investment and Deal Trends

In this podcast, The Bio Report’s Daniel Levine interviews BIO’s Dave Thomas on the recent release of a new BIO Industry Analysis report – Emerging Therapeutic Company Investment and Deal Trends – highlighting ten years (2005-2014) of biotechnology funding and deal making across five areas: venture capital, IPOs, follow-on public offerings, licensing, and acquisitions. The report also offers a first-time look at the degree of collaboration across the industry’s clinical pipeline. Some of the key findings Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , ,

BIO Is Almost Here – What To Consider Before Entering New Therapeutic Areas

BIO International Convention

Over the past decade, the biopharmaceutical industry has witnessed a shift towards specialty care. From 2008 to 2014, FDA specialty drug approvals jumped from 33 percent to over 50 percent of all approvals. In 2014, the FDA approved a record 19 specialty care medicines. Given this new reality, companies are expanding the focus of their R&D into new therapeutic areas to address difficult-to-treat, specialty care conditions. Building successful franchises requires a strategic approach to determine the Read More >

Business and Investments, Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

The International Space Station Brings Big Buzz and Big Science to BIO 2015

BIO International Convention

This year, the BIO International Convention will raise the bar, yet again, through a collaborative effort with CASIS and NASA to showcase space research at this year’s convention. CASIS, the nonprofit organization that manages the U.S. National Laboratory on the International Space Station (ISS), is pioneering a new wave of innovation in space research by connecting commercial R&D leaders to the world’s unique orbiting research platform. Currently, biosciences are a key focus area for CASIS Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,